DK0778024T3 - Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen - Google Patents

Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen

Info

Publication number
DK0778024T3
DK0778024T3 DK97101631T DK97101631T DK0778024T3 DK 0778024 T3 DK0778024 T3 DK 0778024T3 DK 97101631 T DK97101631 T DK 97101631T DK 97101631 T DK97101631 T DK 97101631T DK 0778024 T3 DK0778024 T3 DK 0778024T3
Authority
DK
Denmark
Prior art keywords
camptothecin
oral
insoluble
water
lactone ring
Prior art date
Application number
DK97101631T
Other languages
English (en)
Inventor
Beppino C Giovanella
Hellmuth R Hinz
Anthony J Kozielski
John S Stehlin
Original Assignee
Stehlin Foundation For Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stehlin Foundation For Cancer filed Critical Stehlin Foundation For Cancer
Application granted granted Critical
Publication of DK0778024T3 publication Critical patent/DK0778024T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK97101631T 1993-01-15 1994-01-14 Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen DK0778024T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US284493A 1993-01-15 1993-01-15

Publications (1)

Publication Number Publication Date
DK0778024T3 true DK0778024T3 (da) 2002-12-23

Family

ID=21702794

Family Applications (3)

Application Number Title Priority Date Filing Date
DK02015200T DK1250926T3 (da) 1993-01-15 1994-01-14 Anvendelse af vanduoplöseligt S-camptothecin med en lukket lactonring i fremstilling af et medikament til behandling af coloncancer
DK97101631T DK0778024T3 (da) 1993-01-15 1994-01-14 Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen
DK94907804T DK0678025T3 (da) 1993-01-15 1994-01-14 Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02015200T DK1250926T3 (da) 1993-01-15 1994-01-14 Anvendelse af vanduoplöseligt S-camptothecin med en lukket lactonring i fremstilling af et medikament til behandling af coloncancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94907804T DK0678025T3 (da) 1993-01-15 1994-01-14 Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform

Country Status (9)

Country Link
EP (3) EP1250926B1 (da)
JP (1) JP3099128B2 (da)
AT (3) ATE165003T1 (da)
CA (1) CA2148822C (da)
DE (3) DE69435084T2 (da)
DK (3) DK1250926T3 (da)
ES (3) ES2301590T3 (da)
PT (1) PT1250926E (da)
WO (1) WO1994015604A1 (da)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
NZ235329A (en) * 1989-09-15 1992-01-29 Res Triangle Inst 20(s or rs)-camptothecin derivatives and pharmaceutical compositions
US5422344A (en) * 1990-05-08 1995-06-06 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method of treating retroviral infections in mammals
EP0540099B1 (en) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
EP1393729A3 (en) * 1991-11-15 2004-03-17 Smithkline Beecham Corporation Combination chemotherapy involving topotecan and a platinum coordination compound
CA2125293A1 (en) * 1991-12-10 1993-06-24 Randall Keith Johnson Treatment of colorectal cancer

Also Published As

Publication number Publication date
CA2148822C (en) 2001-03-27
PT1250926E (pt) 2008-06-11
EP1250926A2 (en) 2002-10-23
EP0778024B1 (en) 2002-11-13
DE69435084D1 (de) 2008-04-24
ES2186812T3 (es) 2003-05-16
DE69435084T2 (de) 2009-03-19
CA2148822A1 (en) 1994-07-21
ES2114681T3 (es) 1998-06-01
EP1250926A3 (en) 2002-11-20
ATE388706T1 (de) 2008-03-15
EP0778024A1 (en) 1997-06-11
EP1250926B1 (en) 2008-03-12
DK1250926T3 (da) 2008-07-07
DK0678025T3 (da) 1998-10-07
EP0678025A1 (en) 1995-10-25
ATE227573T1 (de) 2002-11-15
JPH08505626A (ja) 1996-06-18
DE69409633D1 (de) 1998-05-20
DE69431731T2 (de) 2003-03-13
JP3099128B2 (ja) 2000-10-16
WO1994015604A1 (en) 1994-07-21
DE69431731D1 (de) 2002-12-19
ATE165003T1 (de) 1998-05-15
EP0678025B1 (en) 1998-04-15
ES2301590T3 (es) 2008-07-01
DE69409633T2 (de) 1998-08-06

Similar Documents

Publication Publication Date Title
DK203787D0 (da) Praeparat til nasal administrering
FI862011A (fi) Terapeutiska nukleosider.
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
CY1109311T1 (el) Φαρμακευτικο σκευασμα το οποιο περιεχει εποθιλονη
DK538888A (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
ATE79256T1 (de) Zusammensetzung gegen coccidiosis.
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK0778024T3 (da) Oral eller intramuskulær behandling af pancreascancer med vanduopløselig S-camptothecin i lukket lactonring-formen
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE69233773D1 (de) Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs
SG48723A1 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
DK0457336T3 (da) Ny anvendelse af 4-carbamoyl-1-beta-D-ribofuranosylimidazolium-5-olat
DE3683550D1 (de) Verwendung eines quinazolinons zur herstellung eines arzneimittels gegen vertigo und pharmazeutische zusammensetzung.
ES2056374T3 (es) Mejoras en compuestos quimicos.